Two recent publications of a KRAS activation mouse model, also a common aberration in ICC, showed that Pten−/− mice exclusively developed ICCs, whereas Pten+/− mice formed ICC and HCC [35] or mixed differentiated tumors [36]. The gene discussed is KRAS; the disease is intrahepatic cholangiocarcinoma.